Results 11 to 20 of about 566,677 (227)

Coronavirus disease 2019 (COVID-19) and autoimmunity

open access: yesНаучно-практическая ревматология, 2021
The coronavirus 2019 pandemic (coronavirus disease, COVID-19), etiologically related to the SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus-2), has once again reawakened healthcare professionals’ interest towards new clinical and ...
E. L. Nasonov
doaj   +3 more sources

Diabetes and coronavirus disease-2019 (COVID-19)

open access: yesJournal of Diabetology, 2020
Ever since the coronavirus disease (COVID) pandemic started hitting the world, the connection between diabetes and coronavirus disease-2019 (COVID-19) started becoming more clear.
Ranjit Unnikrishnan   +8 more
doaj   +3 more sources

COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease

open access: yesInfection and Drug Resistance, 2020
Amin Sadeghi Dousari,1 Majid Taati Moghadam,2,3 Naghmeh Satarzadeh4,5 1Department of Microbiology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran; 2Department of Microbiology, School of Medicine, Iran University of Medical ...
Sadeghi Dousari A   +2 more
doaj   +4 more sources

Otorhinolaryngologists and Coronavirus Disease 2019 (COVID-19) [PDF]

open access: yesInternational Archives of Otorhinolaryngology, 2020
Geraldo Pereira Jotz   +2 more
doaj   +5 more sources

Resolution of coronavirus disease 2019 (COVID-19) [PDF]

open access: yesExpert Review of Anti-infective Therapy, 2020
Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. The current management of COVID-19 is based generally on supportive therapy and treatment to prevent respiratory failure.
Habas, Khaled   +7 more
openaire   +4 more sources

The management of coronavirus disease 2019 (COVID‐19) [PDF]

open access: yesJournal of Medical Virology, 2020
AbstractIn December 2019, a novel coronavirus causing severe acute respiratory disease occurred in Wuhan, China. It is an emerging infectious disease with widespread and rapid infectiousness. The World Health Organization declared the coronavirus outbreak to be a public health emergency of international concern on 31 January 2020.
Liu, Jialin, Liu, Siru
openaire   +3 more sources

Update on Coronavirus Disease 2019 (COVID-19) [PDF]

open access: yesThe Open Neurology Journal, 2020
n ...
Teresa A Santantonio   +2 more
openaire   +5 more sources

Bacterial coinfections with coronavirus disease 2019 (COVID-19) [PDF]

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2021
Abstract Background: The pandemic caused by severe acute respiratory coronavirus virus 2 (SARS-CoV-2) has dramatically increased cheshospitalizations, and it is often difficult to determine whether there is a bacterial or fungal coinfection at time of presentation.
Glen Huang   +4 more
openaire   +4 more sources

Coronavirus Disease-2019 (COVID-19) and the Liver

open access: yesJournal of Clinical and Translational Hepatology, 2021
Within a year of its emergence, coronavirus disease-2019 (COVID-19) has evolved into a pandemic. What has emerged during the past 1 year is that, apart from its potentially fatal respiratory presentation from which the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) derives its name, it presents with a myriad of gastrointestinal (GI) and ...
Shalimar   +5 more
openaire   +3 more sources

Coronavirus disease 2019 (COVID-19) and QTc prolongation [PDF]

open access: yesBMC Cardiovascular Disorders, 2021
Abstract Introduction The cause-and-effect relationship of QTc prolongation in Coronavirus disease 2019 (COVID-19) patients has not been studied well. Objective We attempt to better understand the relationship of QTc prolongation in COVID-19 patients in this study.
Rehana Bashir   +10 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy